Angina : News

Healthline's Premium Tools

Pill Finder
Search by color, shape and markings. click here
Drug Interaction Checker
Check any 2 drugs for interactions. click here
Drug Compare
Compare any two drugs side by side. click here
Healthline Part D Plan Selector Medicare Part D
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
A study has found that "an NHS test to assess a patient's risk of heart attack is worthless," according to the Daily Mail today.
Source:Scotsman.com Business - Health News from NHS Choices
Date:November 15, 2008
Main Category: Cardiovascular / Cardiology Also Included In: Primary Care / General Practice Article Date: 15 Nov 2008 A study published on bmj.com finds that the electrocardiograms usually given to people with ...
Source:MediLexicon
Date:November 15, 2008
The high cost of angioplasty may not justify the marginal benefit, a new study suggests.
Source:WOIO
Date:November 12, 2008
CV Therapeutics Inc. winnowed its loss by 26 percent in the third quarter, the biopharmaceutical company said Thursday, because of improved sales of its angina drug Ranexa and greater royalty and collaboration ...
Source:International Business Times
Date:November 6, 2008
Shares of the Palo Alto, Calif.-based company were up 85 cents, or 8.8%, at $10.55. Chronic angina, or debilitating chest pain, affects more than 9 million people in the U.S., according to the company.
Source:TheStreet.com
Date:November 6, 2008
The study involved almost 900 patients from Canada and internationally with documented coronary artery disease and a history of stable angina.
Source:Science Daily
Date:November 4, 2008
Thousands of Britons are missing out on an effective treatment for angina - simply because most doctors know nothing about it.
Source:Daily Mail
Date:November 3, 2008
Results from a late-breaking clinical trial, presented at the 2008 Canadian Cardiology Congress in Toronto, show for the first time that combining the pure heart rate reduction medication ivabradine to current ...
Source:MediLexicon
Date:October 31, 2008
MONTREAL HEART INSTITUTE LEAD INVESTIGATOR PRESENTS AT LATE BREAKING CLINICAL TRIAL SESSION MONTREAL, Oct.
Source:Canada NewsWire
Date:October 29, 2008
Lead investigator, from the Universite de Montreal and the Montreal Heart Institute, presents findings from clinical trial Results from a late-breaking clinical trial, presented at the 2008 Canadian Cardiology ...
Source:EurekAlert!
Date:October 28, 2008
Advertisement
Back to Top